Actively Recruiting
Effect of Immersive Virtual Reality With Multisensory Stimulation on the Functional Impact of Hemineglect Secondary to a Right-Sided Stroke: A Single Case Experimental Design Study
Led by Hopital La Musse · Updated on 2025-05-11
3
Participants Needed
1
Research Sites
11 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Stroke is a common and serious condition, affecting many individuals each year and often leading to cognitive impairments such as hemineglect. Hemineglect causes difficulty responding to stimuli on one side, typically after a right hemisphere stroke, and often persists long-term, impacting daily function and rehabilitation outcomes. This research explores the use of immersive virtual reality combined with multisensory stimulation to reduce the functional effects of hemineglect in adults who have experienced a right-sided stroke within the past three months. The study involves a pilot design with repeated evaluation and rehabilitation sessions conducted in a hospital setting. Participants will undergo weekly assessments for 10 to 12 weeks using the Catherine Bergego Scale to measure how hemineglect affects autonomy. After an initial evaluation phase lasting 3 to 5 weeks, patients will receive three weekly 45-minute rehabilitation sessions over five weeks, including a 15-minute immersive virtual reality experience using the VirtySens ae multisensory travel capsule. This capsule stimulates four senses simultaneously through visual, auditory, olfactory, and tactile inputs. During the study, participants will attend weekly evaluation sessions led by occupational therapists who will assess the impact of hemineglect and monitor tolerance to virtual reality. Rehabilitation sessions include review and explanation components, with a focus on patient comfort and response to the virtual reality treatment. The study aims to measure changes in autonomy, awareness of hemineglect, and the ability to tolerate the immersive environment over the 12-week period.
CONDITIONS
Brief Title
Effect of Immersive Virtual Reality With Multisensory Stimulation on the Functional Impact of Hemineglect Secondary to a Right-Sided Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient aged over 18 years
- Diagnosed with first ischemic right stroke confirmed by clinical exam and brain imaging
- Stroke occurred less than 3 months ago
- Presence of left hemineglect diagnosed with the Neglect Assessment Battery
- Normal vision or vision corrected to normal
- Patient affiliated with the social security system
You will not qualify if you...
- History of neurological or psychiatric illness
- Epilepsy
- Craniotomy
- Limited cervical motion due to orthopedic disorders
- Moderate or severe deafness (40 dB hearing loss in one ear)
- Anosmia (loss of smell)
- Asthmatic disease
- Pregnant or suspected pregnant women
- Breastfeeding women
- Severe neurocognitive disorders with MMSE score below 21
- Patient under legal protection measures
- Minor patients
- Patient enrolled in another research protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - 3 to 5 weeks
Participants complete weekly evaluation sessions to measure the impact of hemineglect on autonomy using the Catherine Bergego Scale. These sessions also assess anosognosia and tolerance to immersive virtual reality.
Weekly visits for 3 to 5 weeks
Duration - 5 weeks
Participants undergo three weekly rehabilitation sessions per week for 5 weeks. Each session lasts 45 minutes and includes a 15-minute multisensory immersive virtual reality experience designed for rehabilitation, with tolerance assessments after each session.
3 sessions per week for 5 weeks
Duration - 2 to 4 weeks
Weekly evaluation sessions continue to measure the impact of hemineglect on autonomy, anosognosia, and tolerance to virtual reality after the treatment period.
Weekly visits for 2 to 4 weeks
Trial Site Locations
Total: 1 location
1
Hôpital La Musse
Saint-Sébastien-de-Morsent, France, 27180
Actively Recruiting
Research Team
H
Héloïse BAILLET, PhD
J
Julie LE BALC'H
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here